PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 28702085-5 2017 The lactic acid concentration was 9.36 +- 0.95 g L-1 over a 33-day semi-continuous operation, and converted to caproic acid at pH 5.5-6.2, with a concentration of 4.09 +- 0.54 g L-1 during stable production. Lactic Acid 4-15 immunoglobulin kappa variable 1-16 Homo sapiens 49-52 30098415-7 2019 The presence of lactic acid also substantially affected the removal of phosphate from RFB when 132 mg L-1 phosphate was initially present: after 120 min, only 28.6 mg L-1 of phosphate had been removed. Lactic Acid 16-27 immunoglobulin kappa variable 1-16 Homo sapiens 102-105 30098415-7 2019 The presence of lactic acid also substantially affected the removal of phosphate from RFB when 132 mg L-1 phosphate was initially present: after 120 min, only 28.6 mg L-1 of phosphate had been removed. Lactic Acid 16-27 immunoglobulin kappa variable 1-16 Homo sapiens 167-170 30032876-7 2018 Lactate elevation (>4.0 mM L-1) was associated with 86.1% specificity and 67.8% positive predictive value for massive transfusion. Lactic Acid 0-7 immunoglobulin kappa variable 1-16 Homo sapiens 30-33 30032876-8 2018 When combining elevated lactate concentrations (>4.0 mM L-1) with a shock index >1.0, the specificity and positive predictive value increased to 95.5% and 82.4%, respectively. Lactic Acid 24-31 immunoglobulin kappa variable 1-16 Homo sapiens 59-62 28702085-5 2017 The lactic acid concentration was 9.36 +- 0.95 g L-1 over a 33-day semi-continuous operation, and converted to caproic acid at pH 5.5-6.2, with a concentration of 4.09 +- 0.54 g L-1 during stable production. Lactic Acid 4-15 immunoglobulin kappa variable 1-16 Homo sapiens 178-181 29195878-6 2016 The production and release of 2g L-1 of lactic acid was achieved through encapsulation of L. plantarum, after 20h. Lactic Acid 40-51 immunoglobulin kappa variable 1-16 Homo sapiens 33-36 28467384-2 2017 In batch fermentations, the bioconversion of glucose is strongly inhibited in the presence of more than 100 g L-1 lactic acid and is only possible when the product is simultaneously removed, which can be achieved by ceramic membrane filtration. Lactic Acid 114-125 immunoglobulin kappa variable 1-16 Homo sapiens 110-113 28467384-5 2017 Continuous fermentation under these conditions, thus, achieved a stable productivity of ~8 g L-1 h-1 and the concentration of lactic acid was maintained at ~40 g L-1 at a dilution rate of 0.2 h-1. Lactic Acid 126-137 immunoglobulin kappa variable 1-16 Homo sapiens 162-165 2229281-3 1990 In spite of this, in the diabetic patients lactate (5.1 +/- 0.8 mumol L-1 min-1) and alanine (2.6 +/- 0.4) release by the forearm was 3- and 2-fold higher than in the control group (lactate: 1.7 +/- 0.8, P less than 0.005; and alanine: 1.3 +/- 0.2, P less than 0.05, respectively). Lactic Acid 43-50 immunoglobulin kappa variable 1-16 Homo sapiens 70-79 22869640-6 2013 Postbout blood [La] suggests that boxers must be able to tolerate a lactate production rate of 1.8 mmol L-1 min-1 and maintain skillful techniques at a sufficient activity rate. Lactic Acid 68-75 immunoglobulin kappa variable 1-16 Homo sapiens 106-117 22857018-7 2012 The time taken to reach onset of blood lactate accumulation (OBLA, defined as the point where blood lactate reaches 4 mmol L-1) was significantly increased following 2 weeks of HIT (p = 0.003). Lactic Acid 39-46 immunoglobulin kappa variable 1-16 Homo sapiens 123-126 32182930-7 2020 As a result of the experiments carried out, optimal conditions to remove suspended particles were set at a lactic acid concentration of 1.75 g L-1. Lactic Acid 107-118 immunoglobulin kappa variable 1-16 Homo sapiens 143-146